Cargando…

1676. Evaluation of Antibiotic Overuse for Asymptomatic Bacteriuria in a Hospital with Low Baseline Antibiotic Use

BACKGROUND: In 2019, the Infectious Diseases Society of America published guidelines for the management of asymptomatic bacteriuria (ASB) with recommendations to avoid antimicrobial therapy in most patients. Denver Health has existing guidance for the management of patients with a urinary tract infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kernan, Bailey, Shihadeh, Katherine C, Jenkins, Timothy C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777920/
http://dx.doi.org/10.1093/ofid/ofaa439.1854
_version_ 1783631016109277184
author Kernan, Bailey
Shihadeh, Katherine C
Jenkins, Timothy C
author_facet Kernan, Bailey
Shihadeh, Katherine C
Jenkins, Timothy C
author_sort Kernan, Bailey
collection PubMed
description BACKGROUND: In 2019, the Infectious Diseases Society of America published guidelines for the management of asymptomatic bacteriuria (ASB) with recommendations to avoid antimicrobial therapy in most patients. Denver Health has existing guidance for the management of patients with a urinary tract infection (UTI) and in August of 2019, implemented specific guidance for the management of ASB. As an institution, Denver Health has a Standardized Antimicrobial Administration Ratio (SAAR) of 0.8-0.9, suggesting a strong antimicrobial stewardship program with a ratio of < 1. The purpose of this study is to assess if signs and symptoms were present in patients prescribed an antibiotic for UTI. METHODS: We retrospectively identified hospitalized patients at least 18 years old who were prescribed an antibiotic with “UTI” as the indication from March 1(st) to August 31(st), 2019. Patients with catheter-associated UTIs were excluded. A random sample of 50 cases was manually reviewed for signs and symptoms of infection. Signs were considered fever, defined as at least 38(o)C or leukocytosis, defined as at least 10 k/uL WBC. Symptoms collected were based on documentation of patient reported dysuria, frequency, or urgency, or findings of hematuria. The primary outcome was proportion of patients prescribed an antibiotic for UTI in the absence of signs or symptoms. Prescribing patterns for choice and duration of antimicrobials were also surveyed. RESULTS: A total of 382 antibiotics were prescribed for UTI during the study period. Of the 50 cases reviewed, median age was 65.8 years, with 11% being male. Overall, 29 patients (58%) had no documented symptoms while being treated for UTI. Additionally, 22 patients (44%) had no documented fever, leukocytosis, or urinary symptoms. The most commonly prescribed antibiotics were cefdinir, fosfomycin, and nitrofurantoin. Tables 1 and 2 include additional findings. Table 1 Symptomology and Type of UTI [Image: see text] Table 2 Antimicrobial Choice and Duration [Image: see text] CONCLUSION: Despite a well established stewardship program, nearly half of patients prescribed an antibiotic for UTI did not have signs or symptoms consistent with infection. This suggests many patients were treated for ASB, without necessity. Among hospitals with comparatively low antibiotic use, ASB may be a high-yield opportunity to reduce unnecessary antibiotic use. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777920
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77779202021-01-07 1676. Evaluation of Antibiotic Overuse for Asymptomatic Bacteriuria in a Hospital with Low Baseline Antibiotic Use Kernan, Bailey Shihadeh, Katherine C Jenkins, Timothy C Open Forum Infect Dis Poster Abstracts BACKGROUND: In 2019, the Infectious Diseases Society of America published guidelines for the management of asymptomatic bacteriuria (ASB) with recommendations to avoid antimicrobial therapy in most patients. Denver Health has existing guidance for the management of patients with a urinary tract infection (UTI) and in August of 2019, implemented specific guidance for the management of ASB. As an institution, Denver Health has a Standardized Antimicrobial Administration Ratio (SAAR) of 0.8-0.9, suggesting a strong antimicrobial stewardship program with a ratio of < 1. The purpose of this study is to assess if signs and symptoms were present in patients prescribed an antibiotic for UTI. METHODS: We retrospectively identified hospitalized patients at least 18 years old who were prescribed an antibiotic with “UTI” as the indication from March 1(st) to August 31(st), 2019. Patients with catheter-associated UTIs were excluded. A random sample of 50 cases was manually reviewed for signs and symptoms of infection. Signs were considered fever, defined as at least 38(o)C or leukocytosis, defined as at least 10 k/uL WBC. Symptoms collected were based on documentation of patient reported dysuria, frequency, or urgency, or findings of hematuria. The primary outcome was proportion of patients prescribed an antibiotic for UTI in the absence of signs or symptoms. Prescribing patterns for choice and duration of antimicrobials were also surveyed. RESULTS: A total of 382 antibiotics were prescribed for UTI during the study period. Of the 50 cases reviewed, median age was 65.8 years, with 11% being male. Overall, 29 patients (58%) had no documented symptoms while being treated for UTI. Additionally, 22 patients (44%) had no documented fever, leukocytosis, or urinary symptoms. The most commonly prescribed antibiotics were cefdinir, fosfomycin, and nitrofurantoin. Tables 1 and 2 include additional findings. Table 1 Symptomology and Type of UTI [Image: see text] Table 2 Antimicrobial Choice and Duration [Image: see text] CONCLUSION: Despite a well established stewardship program, nearly half of patients prescribed an antibiotic for UTI did not have signs or symptoms consistent with infection. This suggests many patients were treated for ASB, without necessity. Among hospitals with comparatively low antibiotic use, ASB may be a high-yield opportunity to reduce unnecessary antibiotic use. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777920/ http://dx.doi.org/10.1093/ofid/ofaa439.1854 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Kernan, Bailey
Shihadeh, Katherine C
Jenkins, Timothy C
1676. Evaluation of Antibiotic Overuse for Asymptomatic Bacteriuria in a Hospital with Low Baseline Antibiotic Use
title 1676. Evaluation of Antibiotic Overuse for Asymptomatic Bacteriuria in a Hospital with Low Baseline Antibiotic Use
title_full 1676. Evaluation of Antibiotic Overuse for Asymptomatic Bacteriuria in a Hospital with Low Baseline Antibiotic Use
title_fullStr 1676. Evaluation of Antibiotic Overuse for Asymptomatic Bacteriuria in a Hospital with Low Baseline Antibiotic Use
title_full_unstemmed 1676. Evaluation of Antibiotic Overuse for Asymptomatic Bacteriuria in a Hospital with Low Baseline Antibiotic Use
title_short 1676. Evaluation of Antibiotic Overuse for Asymptomatic Bacteriuria in a Hospital with Low Baseline Antibiotic Use
title_sort 1676. evaluation of antibiotic overuse for asymptomatic bacteriuria in a hospital with low baseline antibiotic use
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777920/
http://dx.doi.org/10.1093/ofid/ofaa439.1854
work_keys_str_mv AT kernanbailey 1676evaluationofantibioticoveruseforasymptomaticbacteriuriainahospitalwithlowbaselineantibioticuse
AT shihadehkatherinec 1676evaluationofantibioticoveruseforasymptomaticbacteriuriainahospitalwithlowbaselineantibioticuse
AT jenkinstimothyc 1676evaluationofantibioticoveruseforasymptomaticbacteriuriainahospitalwithlowbaselineantibioticuse